Literature DB >> 16961300

Expression of CD40 and CD40L on peripheral blood mononuclear cells in patients with condyloma acuminatum.

Dongxian Liu1, Wen Jiang, Xingping Chen, Yingling Chen, Dongliang Yang.   

Abstract

To observe the expression of CD40/CD40L on peripheral blood mononuclear cells (PBMC) in patients with condyloma acuminatum (CA), flow cytometry was employed to examine the expression of CD40 and CD40L on PMBC in 36 patients with CA and 20 healthy controls. Our results showed that mean level of CD40 expression in CA patients was significantly lower than that in the controls (6.58% +/- 2.74% vs 14.81% +/- 6.12%, t = 5.703, P < 0.05); the average level of CD40L in CA patients was also significantly lower than that in the controls (0.73% +/- 0.54% vs 2.67% +/- 2.43%, t = 3.532, P < 0.05). Our results suggest that the reduced costimulatory interaction of CD40 and CD40L in CA patients may be one of the important factors responsible for the low cellular immunity.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16961300     DOI： 10.1007/bf02829582

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN： 1672-0733


  7 in total

Review 1.  Potential strategies utilised by papillomavirus to evade host immunity.

Authors:  I H Frazer; R Thomas; J Zhou; G R Leggatt; L Dunn; N McMillan; R W Tindle; L Filgueira; P Manders; P Barnard; M Sharkey
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

Review 2.  The role of CD40 in peripheral T cell tolerance and immunity.

Authors:  L Diehl; A T Den Boer; E I van der Voort; C J Melief; R Offringa; R E Toes
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

3.  In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.

Authors:  Y Sun; D Peng; J Lecanda; V Schmitz; M Barajas; C Qian; J Prieto
Journal:  Gene Ther       Date:  2000-09       Impact factor: 5.250

4.  Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection.

Authors:  R Matorras; J M Ariceta; A Rementeria; J Corral; G Gutierrez de Terán; J Diez; F Montoya; F J Rodriguez-Escudero
Journal:  Am J Obstet Gynecol       Date:  1991-01       Impact factor: 8.661

5.  The role of the immune system in anogenital human papillomavirus.

Authors:  I H Frazer
Journal:  Australas J Dermatol       Date:  1998-11       Impact factor: 2.875

6.  [Vulvo-vaginal HPV infection: immunological aspects].

Authors:  R Zarcone; P Bellini; G Cardone; A Castagnolo; N Colacurci
Journal:  Minerva Ginecol       Date:  1996-03

Review 7.  Immunology of papillomavirus infection.

Authors:  I H Frazer
Journal:  Curr Opin Immunol       Date:  1996-08       Impact factor: 7.486
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.